11:20am ET
Health and Healthcare
Why One Analyst Sees Gilead Worth 66% More
Argus reiterated Gilead Sciences as Buy, but hat really matters here is that Argus has a $150 price target on the stock.
Jon C. Ogg
Companies
/Healthcare
Gilead Sciences Inc
$146.46
▼ $0.19 (−0.13%) today
Markets open · 10:34am ET
GILD Coverage
Page 29 Jon C. Ogg 8:05am ET
Health and Healthcare
Short Sellers Back Off of Major Biotechs
The February 29 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
11:56am ET
Health and Healthcare
Big Pharma Matchup: Valeant vs Gilead
Here are two big biopharmas, both with multibillion dollar portfolios and both of which have lost a combined $113 billion in market cap since August.
5:15pm ET
Health and Healthcare
Why Citi Sees Huge Upside in 4 Top Biotechs Now
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
8:46am ET
Health and Healthcare
Short Interest Rises Across the Board in Major Biotechs
The February 12 short interest data have been compared with the previous report, and short interest increased across the board in these selected biotech stocks.
7:25am ET
Investing
The 18 Companies That Will Buy Back the Most Stock in 2016
It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most buying back their common stock this year alone.
9:32am ET
Health and Healthcare
6 Biotech and Pharma Stocks Analysts Want You to Buy Now
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Activision Blizzard, Boeing, FireEye, Gilead, Groupon, Netflix, Pandora and More
The top analyst upgrades, downgrades and initiations seen on Friday include Activision Blizzard, Boeing, FireEye, Gilead Sciences, Groupon, Netflix and Pandora Media.
8:40am ET
Health and Healthcare
Major Biotech Short Interest Continues to Be Mixed
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most of the selected biotech stocks.
10:50am ET
Health and Healthcare
How Analysts Value Gilead Now After Earnings
After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction it might go next.
Chris Lange 4:31pm ET
Health and Healthcare
Gilead Rises on Solid HCV Sales and Earnings Beat
Gilead Sciences reported better-than-expected fourth-quarter financial results after the markets closed on Tuesday.
Chris Lange 4:04pm ET
Investing
Tesla Hits 52-Week Low
February 2, 2016: Here are five stocks trading with heavy volume among 209 equities making new 52-week lows today. Tesla Motors Inc. (NASDAQ: TSLA) dropped about 8.5% on Tuesday, posting a new 52-week…
12:55pm ET
Health and Healthcare
What Expect From Gilead Earnings
Gilead Sciences is set to release its fourth-quarter earnings report after the markets close on Tuesday.
Chris Lange 4:04pm ET
Investing
The 52-Week Low Club for Monday
February 1, 2016: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows today. Gilead Sciences Inc. (NASDAQ: GILD) dropped about 0.9% on Monday to post a…
9:50am ET
Health and Healthcare
The 4 Largest Biotech Stocks Are Cheaper Than S&P 500
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the S&P for the first time since early in 2011, despite displaying higher…
